Updated
Updated · Blackchronicle · May 30
Scientists Identify New Liver Cell Cluster in MASH, Opening 1 Therapeutic Target
Updated
Updated · Blackchronicle · May 30

Scientists Identify New Liver Cell Cluster in MASH, Opening 1 Therapeutic Target

3 articles · Updated · Blackchronicle · May 30

Summary

  • A newly identified cluster of liver cells appears only in livers affected by MASH, a severe metabolic liver disease that can progress to cancer.
  • Researchers reported in The Journal of Clinical Investigation that the cells activate a gene helping the liver adapt to metabolic stress, pointing to a mechanism behind disease response.
  • That pathway could give drug developers a new therapeutic target to shield the liver from chronic damage and slow or stop metabolic disease progression.
  • The finding adds to efforts to better understand MASH, a condition tied to metabolic dysfunction and a growing source of serious liver illness.

Insights

As new drugs for 'silent' liver disease emerge, how will healthcare systems find and treat millions of undiagnosed patients?
Since obesity's damage to the brain is reversible, what is the optimal strategy to restore cognitive function?
With AI discovering new drugs in marine microbes, how close are we to defeating antibiotic-resistant superbugs?